225 related articles for article (PubMed ID: 24091661)
1. Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes.
Česen MH; Repnik U; Turk V; Turk B
Cell Death Dis; 2013 Oct; 4(10):e818. PubMed ID: 24091661
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation.
Ostenfeld MS; Høyer-Hansen M; Bastholm L; Fehrenbacher N; Olsen OD; Groth-Pedersen L; Puustinen P; Kirkegaard-Sørensen T; Nylandsted J; Farkas T; Jäättelä M
Autophagy; 2008 May; 4(4):487-99. PubMed ID: 18305408
[TBL] [Abstract][Full Text] [Related]
3. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.
Ostenfeld MS; Fehrenbacher N; Høyer-Hansen M; Thomsen C; Farkas T; Jäättelä M
Cancer Res; 2005 Oct; 65(19):8975-83. PubMed ID: 16204071
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal and mitochondrial permeabilization mediates zinc(II) cationic phthalocyanine phototoxicity.
Marino J; García Vior MC; Furmento VA; Blank VC; Awruch J; Roguin LP
Int J Biochem Cell Biol; 2013 Nov; 45(11):2553-62. PubMed ID: 23994488
[TBL] [Abstract][Full Text] [Related]
5. L-leucyl-L-leucine methyl ester does not release cysteine cathepsins to the cytosol but inactivates them in transiently permeabilized lysosomes.
Repnik U; Borg Distefano M; Speth MT; Ng MYW; Progida C; Hoflack B; Gruenberg J; Griffiths G
J Cell Sci; 2017 Sep; 130(18):3124-3140. PubMed ID: 28754686
[TBL] [Abstract][Full Text] [Related]
6. Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism.
Dielschneider RF; Eisenstat H; Mi S; Curtis JM; Xiao W; Johnston JB; Gibson SB
Leukemia; 2016 Jun; 30(6):1290-300. PubMed ID: 26859075
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells.
Jonhede S; Petersen A; Zetterberg M; Karlsson JO
Mol Vis; 2010 May; 16():819-27. PubMed ID: 20461150
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.
Ma S; Henson ES; Chen Y; Gibson SB
Cell Death Dis; 2016 Jul; 7(7):e2307. PubMed ID: 27441659
[TBL] [Abstract][Full Text] [Related]
9. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
10. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine.
Groth-Pedersen L; Ostenfeld MS; Høyer-Hansen M; Nylandsted J; Jäättelä M
Cancer Res; 2007 Mar; 67(5):2217-25. PubMed ID: 17332352
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer.
Hornick JR; Vangveravong S; Spitzer D; Abate C; Berardi F; Goedegebuure P; Mach RH; Hawkins WG
J Exp Clin Cancer Res; 2012 May; 31(1):41. PubMed ID: 22551149
[TBL] [Abstract][Full Text] [Related]
12. Poloxamer 188 attenuates in vitro traumatic brain injury-induced mitochondrial and lysosomal membrane permeabilization damage in cultured primary neurons.
Luo CL; Chen XP; Li LL; Li QQ; Li BX; Xue AM; Xu HF; Dai DK; Shen YW; Tao LY; Zhao ZQ
J Neurotrauma; 2013 Apr; 30(7):597-607. PubMed ID: 23186154
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal membrane permeabilization: carbon nanohorn-induced reactive oxygen species generation and toxicity by this neglected mechanism.
Yang M; Zhang M; Tahara Y; Chechetka S; Miyako E; Iijima S; Yudasaka M
Toxicol Appl Pharmacol; 2014 Oct; 280(1):117-26. PubMed ID: 25110057
[TBL] [Abstract][Full Text] [Related]
14. Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist.
Spirkoski J; Melo FR; Grujic M; Calounova G; Lundequist A; Wernersson S; Pejler G
Biochem Pharmacol; 2012 Dec; 84(12):1671-80. PubMed ID: 23058984
[TBL] [Abstract][Full Text] [Related]
15. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.
Hernández-Tiedra S; Fabriàs G; Dávila D; Salanueva ÍJ; Casas J; Montes LR; Antón Z; García-Taboada E; Salazar-Roa M; Lorente M; Nylandsted J; Armstrong J; López-Valero I; McKee CS; Serrano-Puebla A; García-López R; González-Martínez J; Abad JL; Hanada K; Boya P; Goñi F; Guzmán M; Lovat P; Jäättelä M; Alonso A; Velasco G
Autophagy; 2016 Nov; 12(11):2213-2229. PubMed ID: 27635674
[TBL] [Abstract][Full Text] [Related]
16. Dependence of glucose transport on autophagy and GAPDH activity.
Craven RJ; Frazier HN; Thibault O
Brain Res; 2022 Feb; 1776():147747. PubMed ID: 34864044
[TBL] [Abstract][Full Text] [Related]
17. The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway.
Chen W; Li N; Chen T; Han Y; Li C; Wang Y; He W; Zhang L; Wan T; Cao X
J Biol Chem; 2005 Dec; 280(49):40985-95. PubMed ID: 16188880
[TBL] [Abstract][Full Text] [Related]
18. Combination of Hydroxyl Acetylated Curcumin and Ultrasound Induces Macrophage Autophagy with Anti-Apoptotic and Anti-Lipid Aggregation Effects.
Zheng L; Li Y; Li X; Kou J; Zhong Z; Jiang Y; Liu Z; Tian Y; Yang L
Cell Physiol Biochem; 2016; 39(5):1746-1760. PubMed ID: 27744450
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells.
Hsu KF; Wu CL; Huang SC; Wu CM; Hsiao JR; Yo YT; Chen YH; Shiau AL; Chou CY
Autophagy; 2009 May; 5(4):451-60. PubMed ID: 19164894
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion.
Boya P; Andreau K; Poncet D; Zamzami N; Perfettini JL; Metivier D; Ojcius DM; Jäättelä M; Kroemer G
J Exp Med; 2003 May; 197(10):1323-34. PubMed ID: 12756268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
